Answers are grounded in this paper and cite their sources.
Prospective study reveals high rates of fatal pneumonia from respiratory syncytial virus in adult leukemia patients, highlighting the threat of seasonal viral infections in myelosuppressed hosts.
Respiratory syncytial virus (RSV) has been demonstrated to be an important cause of life-threatening pneumonia in adult bone marrow transplant recipients; however, its role in other immunocompromised adults has not been defined. We prospectively studied all adult patients with leukemia who were hospitalized at M. D. Anderson Cancer Center (Houston) during a 1-year period (November 1993 through October 1994). During a 19-week period when RSV was prevalent in the community, it was isolated from 9 (10%) of 87 patients with leukemia who developed an acute respiratory illness. In 6 (75%) of 8 patients with profound chemotherapy-induced myelosuppression, the RSV infection was complicated by pneumonia, with an 83% mortality rate. RSV appears to be an important cause of severe and often fatal pneumonia in myelosuppressed patients with leukemia.
No takes yet. Share an insight, caveat, or question.
Whimbey et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: